课题基金 / 基金详情

Pre-clinical development of broad-spectrum antiviral strategies against human respiratory viruses of pandemic concern

Pre-clinical development of broad-spectrum antiviral strategies against human respiratory viruses of pandemic concern
针对大流行病的人类呼吸道病毒的广谱抗病毒策略的临床前开发
批准号:
462582
负责人:
Jean François
金额:
$68.88万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2026-03-01

项目摘要

项目成果

Jean François的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Respiratory viruses such as SARS-CoV-2 (the virus causing COVID-19) and Influenza A virus, have inarguably had an enormous impact on human health. Although vaccines have greatly limited COVID-19 and Influenza-related hospitalizations and deaths, these vir
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-clinical development of a novel class of broad-spectrum natural product antivirals
  • 批准号:
    480228
  • 项目类别:
    Operating Grants
  • 资助金额:
    $57.4万
  • 财政年份:
    2023
  • 负责人:
    Jean François
  • 依托单位:
Development and application of mass-spectrometry-based multiplexing assays for detecting Zika virus and uncovering novel anti-flaviviral strategies
  • 批准号:
    366553
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Jean François
  • 依托单位:
Molecular and cellular studies of novel subtilase-directed secretory pathway serpins
  • 批准号:
    178316
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2008
  • 负责人:
    Jean François
  • 依托单位:
海外基金